166 related articles for article (PubMed ID: 9452776)
1. [Nitric oxide and circulatory homeostasis].
Arnal JF
Ann Cardiol Angeiol (Paris); 1997; 46(7):420-5. PubMed ID: 9452776
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and biological investigation of NO].
Darblade B; Privat C; Caillaud D; Rami J; Arnal JF
J Soc Biol; 2000; 194(3-4):151-7. PubMed ID: 11324317
[TBL] [Abstract][Full Text] [Related]
3. [Endothelium-derived relaxing factor/nitrogen oxide. Pharmacological and clinical cardiovascular aspects].
Laursen JB; Boesgaard S; Poulsen HE; Aldershvile J
Ugeskr Laeger; 1994 Sep; 156(39):5661-6. PubMed ID: 7985247
[TBL] [Abstract][Full Text] [Related]
4. [Endothelial functions in cardiovascular diseases].
Mügge A; Förstermann U; Lichtlen PR
Z Kardiol; 1989 Mar; 78(3):147-60. PubMed ID: 2652905
[TBL] [Abstract][Full Text] [Related]
5. [Endothelium-derived relaxing factor(s): endogenous nitrates in the circulation?].
Lüscher TF; Yang Z; Diederich D; Schneider K; von Segesser L; Siebenmann R; Stulz P; Bühler FR
Schweiz Med Wochenschr; 1988 Nov; 118(46):1724-9. PubMed ID: 3062771
[TBL] [Abstract][Full Text] [Related]
6. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
Michel JB
Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
[TBL] [Abstract][Full Text] [Related]
7. [The role of endogenous free radicals of nitric oxide (NO)].
Antoni F; Csuka I; Romics L
Orv Hetil; 1992 Mar; 133(13):773-6. PubMed ID: 1560970
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
[TBL] [Abstract][Full Text] [Related]
9. [Nitrates and coronary vascular endothelium dysfunction].
Berdeaux A; Dubois-Randé JL; Hittinger L
Ann Cardiol Angeiol (Paris); 1997; 46(7):391-8. PubMed ID: 9452772
[TBL] [Abstract][Full Text] [Related]
10. Introduction to EDRF research.
Furchgott RF
J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-2. PubMed ID: 7504760
[TBL] [Abstract][Full Text] [Related]
11. [Endothelial dysfunction and atherosclerosis].
Vanhoutte PM
Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():9-19. PubMed ID: 9515109
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of endothelial dysfunction: studies of human coronary circulation in vivo].
Golino P
Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1177-81. PubMed ID: 8248690
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations.
McHugh J; Cheek DJ
Am J Crit Care; 1998 Mar; 7(2):131-40; quiz 141-2. PubMed ID: 9509227
[TBL] [Abstract][Full Text] [Related]
14. [Role of endothelial nitric oxide in the regulation of arterial tone].
Michel JB
Rev Prat; 1997 Dec; 47(20):2251-6. PubMed ID: 9616914
[TBL] [Abstract][Full Text] [Related]
15. Endogenous nitrates--implications for treatment and prevention.
Anggård EE
Eur Heart J; 1991 May; 12 Suppl A():5-8. PubMed ID: 1874272
[TBL] [Abstract][Full Text] [Related]
16. The endothelium in acute coronary syndromes.
Noll G; Lüscher TF
Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
[TBL] [Abstract][Full Text] [Related]
17. [Endothelium derived relaxing factor and its effect on vascular disease].
Wang J; Li Z
Wei Sheng Yan Jiu; 2003 Sep; 32(5):508-10. PubMed ID: 14650203
[TBL] [Abstract][Full Text] [Related]
18. Endogenous and exogenous nitrates.
Anggård EE
Acta Anaesthesiol Scand Suppl; 1992; 97():7-10. PubMed ID: 1557942
[TBL] [Abstract][Full Text] [Related]
19. Exploring vascular benefits of endothelium-derived nitric oxide.
Cockcroft JR
Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
[TBL] [Abstract][Full Text] [Related]
20. [Endothelial dysfunction and vascular pathology].
Vanhoutte PM
Bull Mem Acad R Med Belg; 2006; 161(10-12):529-36; discussion 536-7. PubMed ID: 17503729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
